deepeye

The company develops AI-based medical software designed to assist ophthalmologists in the diagnosis and treatment planning of retinal diseases such as age-related macular degeneration. Its primary product, deepeye TPS, is a CE-marked assistant that provides a second reading of optical coherence tomography (OCT) scans to optimize anti-VEGF therapy. The platform also serves pharmaceutical researchers by analyzing retinal therapy datasets to stratify patients and improve clinical trial outcomes.